FDA-Inspected Site

InfuScience, Inc. dba Bioscrip Infusion Services

2 FDA inspections are on record for InfuScience, Inc. dba Bioscrip Infusion Services in Chantilly, United States.

483· Form 483 issued

Chantilly, United States · Last updated July 11, 2026

Overview

  • 2 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2021-10-08.

At a glance

Inspections

2

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
27 Sep 2021 – 8 Oct 2021Human Drugs483View 483 →
23 Jul 2019 – 30 Jul 2019Human DrugsWLView 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

8 Oct 2021
FDCA 501(a)(2)(A)

Cleanliness, ISO-classified areas

Cited by Sena G Dissmeyer, Marcia D Fields

8 Oct 2021
FDCA 501(a)(2)(A)

First pass air blockage, open unit with sterile product

Cited by Sena G Dissmeyer, Marcia D Fields

30 Jul 2019
FDCA 501(a)(2)(A)

Beta-lactam drugs, inadequate sanitation

Cited by Sena G Dissmeyer

30 Jul 2019
FDCA 501(a)(2)(A)

Cleanliness, ISO-classified areas

Cited by Sena G Dissmeyer

30 Jul 2019
FDCA 501(a)(2)(A)

Disinfectant contact time

Cited by Sena G Dissmeyer

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
FDCA 501(a)(2)(A)Cited across public-safe Form 483 observations8x

Full site report

Get the verbatim findings behind InfuScience, Inc. dba Bioscrip Infusion Services' 2 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat